Src

• http://www.endotext.org/neuroendo/neuroendo6/neuroendo6.html

Prolactinoma and pregnancy

• [endo] incidence of tu expansion during pregnancy: micro|macro-adenoma [not prev'ly op'd/irrad'd]: in {2-5|16-41}%
• if microadenoma: bimonthly clinical evaluation
• bromocriptine safe in 1400 women, and no teratogenicity in animals (--fewer data on cabergoline [NB: action up to 6/52 after drug withdrawal] and quinagolide)